Psychotic disorders affect 3% of the population at some stage in life, are a leading cause of
disability, and impose a great economic burden on society. Major breakthroughs in the …

Background Antipsychotic-induced weight gain is a contributing factor in the reduced life
expectancy reported amongst people with psychotic disorders. CYP2D6 is a liver enzyme …

BackgroundThere is increasing evidence for shared genetic susceptibility between schizophrenia
and bipolar disorder. Although genetic variants only convey subtle increases in risk …

The burden of large and rare copy number genetic variants (CNVs) as well as certain specific
CNVs increase the risk of developing schizophrenia. Several cognitive measures are …

Endophenotypes are mediator traits between genetic influences and clinical phenotypes.
Meta-analyses have consistently shown modest impairments of executive functioning in …

Background: Dyslipidaemia is an important cardiovascular risk factor for people with severe
mental illness, contributing to premature mortality. The link between antipsychotics and …

CYP2D6 and CYP2C19 enzymes are essential in the metabolism of antidepressants and
antipsychotics. Genetic variation in these genes may increase risk of adverse drug reactions. …

Hyperprolactinemia is a known adverse drug reaction to antipsychotic treatment. Antipsychotic
blood levels are influenced by cytochrome P450 enzymes, primarily CYP2D6. Variation in …

Mismatch negativity (MMN) is a differential electrophysiological response measuring
cortical adaptability to unpredictable stimuli. MMN is consistently attenuated in patients with …

The Spiritual Intelligence Self-Report Inventory 24 (SISRI-24) is widely used to assess
spiritual intelligence (SI) in general population samples. The current study explored the Greek …